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SYNOVIAL SARCOMA OF THE PENIS: A CASE REPORT
Chao-An Chen 1, Kam-Fai Lee 2, Kuo-Cai Huang 1, Kuo-Hsiung Chiu 1, Tzu-
Hsin Yang 1, Yin-Lun Chang 1, Jian-Hui Lin 1, Yung-Chin Huang 2, Dong-Ru
Ho 1, Chih-Shou Chen 1, Wei-Yu Lin 1. 1Division of Urology, Department of
Surgery, Chiayi Chang Gung Memorial Hospital, Chiayi, Taiwan;
2Department of Anatomic Pathology, Chiayi Chang Gung Memorial
Hospital, Chiayi, Taiwan
Purpose: Primary synovial sarcoma of the penis is extremely rare. We
report a case of synovial sarcoma initially discovered as a painless penile
mass with no image evidence of distal metastasis. Synovial sarcoma was
reported in the ﬁnal pathology.
Materials and Methods: A 59-year-old male patient is a case of panic
disorder under alprazolam treatment for 4 years. He came to our outpa-
tient department for gradual enlargement of penile mass in recentmonths.
He is a married man without circumcision. The mass was painless,
spherical, and movable over penile base, without skin abnormality or
infection signs. Computed tomography revealed a 3.2 cm hypodense mass
lesion over left side of corpus cavernosum without enlargement of pelvis
or retroperitoneal lymph nodes. Partial penectomy with bilateral inguinal
lymph node dissection was performed. Synovial sarcoma within tunica
abluginea (pT2) was reported in the ﬁnal pathology.
Results: To our knowledge; this is the ﬁrst case of primary synovial sar-
coma of penis in Taiwan.
MP3-4:
ADENOCARCINOMA OF URINARY BLADDERe A CASE REPORT
Ping-Hao Tsai, Heng-Chieh Chiang, Pao-Hwa Chen. Divisions of Urology,
Department of Surgery, Changhua Christian Hospital, Changhua, Taiwan
This 78 years old manwho was under regular follow-up post transurethral
rsection of prostate gland. During last cystoscope, tumor biopsy was done
and the pathologic report reveal possibility of urothelial carcinoma with
glandular differentiation, which primary adenocarcinoma or secondary
adenocarcinoma involvement especially colorectal origin may be consid-
eration on July, 2015.
Afterward, we arranged MRI for tumor staging and it reveals T3N0M0,
Stages III. Then, after explain to patient, transurethral resection of bladder
tumor was performed on Aug, 2015. The ﬁnal pathologic report reveals
adenocarcinoma arising from urinary bladder. We also arranged colon
scope which reveals negative ﬁnding. PET scan reveals no uptake for
gastrointestinal tract.
As exclude colorectal origin of adenocarcinoma, patient is under radio-
therapy and chemotherapy for adneomcarcinoma currently.
MP3-5:
ASSOCIATION BETWEEN HUMAN GLUTATHIONE S-TRANSFERASE
OMEGA RS4925 POLYMORPHISM AND BLADDER CANCER
Zhon-Min Huang 1, Jow-Yu Sheu 1, Min-Che Tung 1, Chia-Chang
Wu2, Yuan-Hung Wang 2. 1Divisions of Urology, Department of Surgery,
Tungs’ Taichung Metro Harbor Hospital, Taichung, Taiwan; 2Divisions of
Urology, Shuang Ho Hospital, Taipei Medical University New Taipei City,
Taiwan
Purpose: Glutathione S-transferases (GSTs) play an important role in the
detoxiﬁcation of polycyclic aromatic hydrocarbons and aromatic amines,
the toxic substances contained in cigarettes. GST Omega 1 (GSTO1) not
only utilizes glutathione in conjugation reaction but also contributes to the
biotransformation of several xenobiotics. A single nucleotide poly-
morphism (Ala- 140Asp) of GSTO1 gene causing variations in enzyme
activity may inﬂuence individual susceptibility to bladder cancer (BC). It is
hypothesized that genetic polymorphism of GSTO1 gene has an effect on
BC risk in particular by interacting with cigarette smoking.
Materials and Methods: A total of histopathologically conﬁrmed 300 BC
patients and 300 cancer-free controlswere recruited fromFebruary 2002 to
February 2009. Genotyping of the GSTO1 Ala140Asp polymorphism was
deter-mined using a polymerase chain reaction-restricted fragment lengthpolymorphism (PCR-RFLP)method. The odds ratio (OR) and 95% conﬁdence
interval (CI)were calculated as ameasureof the combined effectof cigarette
smoking and the GSTO1 Ala140Asp polymorphism on BC risk.
Results: We found that study subjects with the GSTO1 Ala/Ala genotype
have a signiﬁcantly increased BC risk (OR¼ 1.5; 95% CI¼ 1.1e2.7). A sta-
tistically signiﬁcant increased BC risk was also found in ever smokers with
the GSTO1 Ala/Ala genotype (OR¼ 4.9; 95%CI¼ 2.8e9.7).
Conclusions:Thisstudyprovidesanepidemiologic evidenceofa signiﬁcantly
increased BC risk among ever smokers with the GSTO1 Ala/Ala genotype.
MP3-6:
ANALYSIS OF PROSTATE CANCER PATIENTS WITH INVOLVEMENT OF
PROSTATIC ANTERIOR FAT PAD
Wei-Chun Weng 1, Min-Che Tung 1, Jow-Yu Sheu 1, Li-Hua Huang 1, Chun-
Kuang Yang 2, Yen-Chuan Ou 2. 1Divisions of Urology, Department of
Surgery, Tungs' Taichung MetroHarbor Hospital, Taiwan; 2Divisions of
Urology, Department of Surgery, Taichung Veterans General Hospital, Taiwan
Purpose: The presence of lymph nodes within the prostatic anterior fat
pad (PAFP) has been noted in several reports. Metastatic cancer can be
found in PAFP lymph nodes. The characteristics of patients with PAFP
lymph node metastasis are not well described in Taiwanese patients.
Materials and Methods: From December 2006 to May 2014, 770 consec-
utive patients received robot-assisted radical prostatectomy(RARP) with
PAFP dissection bya single surgeon, Yen-ChuanOu.Mean agewas 65.1± 7.1
years. PAFP was removed for pathological examination to evaluate the
presence of lymphoid tissue and the involvement of prostate cancer.
Results: Among these 770 patients, 61(7.92%) patients were detected to
have 1 to 3 PAFP lymph nodes. 52 patients had one node, 7 patients had
two nodes, and 2 patients had three nodes. 6(0.82%) patients had positive
metastasis. In these 6 patients, 2 patients had PAFP metastases only and
the other 4 patients had concomitant pelvic lymph nodes metastases. The
other 55 patients had PAFP nodes but tested negative for malignancy.
Conclusions: Prostate cancer with metastases to the PAFP nodes has
positive correlation with patients who had a high risk of prostate cancer
preoperatively. The removal of the PAFP can facilitate the dissection of the
prostate apex and bladder neck, and can also result in pathological
upstaging if metastasis was present.Moderated Poster-4
other
MP4-1:
UROLITHIASIS IS ASSOCIATED WITH HIGHER PREVALENCE OF LOW
SERUM TESTOSTERONE LEVEL IN PATIENTS WITH ERECTILE
DYSFUNCTION
Yin-Chien Ou, Ho-Shiang Huang, Yung-Ming Lin. Department of Urology,
National Cheng Kung University Hospital, Tainan, Taiwan
Purpose: Both stone disease and erectile dysfunction (ED) are currently
considered as systemic diseases which may associate with
several systemic risk factors, such as hypertension (HTN), diabetes
mellitus (DM), dyslipidemia, smoking, obesity, and hypogonadism. The
aim of this study is to evaluate the prevalence of urolithiasis in
patients with ED, and to show which risk factors may relate to stone
formation.
Materials and Methods: From May 2014 to September 2015, total 186
patients presented to our out-patient clinic with chief complaint of ED
were prospectively enrolled. The clinical characteristics, underlying dis-
eases, current medications, IIEF-5 questionnaire, biochemical proﬁles and
self-report history of urolithiasis were collected. We further divided these
patients into stone positive group and stone negative group. The Fisher’s
exact test were used to evaluate the different prevalence of risk factors
between these two groups.
Results: Of the 186 patients, 21 (11.3%) reported history of urolithiasis, and
were divided in the stone positive group. The other 165 patients were in
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higher but not statistically different from previous study of the general
population of southern Taiwan. The average age, IIEF score, prevalence of
HTN, DM, dyslipidemia, smoking and obesity were compatible between
the two groups without difference. By contrast, 8 (38.1%) patients in the
stone positive group have low serum testosterone level, which is signiﬁ-
cant higher compared to 20 (12.1%) from the stone negative group
(P¼ 0.005).
Conclusions: In patients with ED, we found a higher incidence of stone
prevalence. For ED patients with urolithiasis, higher prevalence of low
serum testosterone level was found compared to those without uroli-
thiasis.
MP4-2:
COMPARISON OF THE POST-OPERATIVE INFECTION BY USING
DIFFERENT TYPE OF PROPHYLACTIC ANTIBIOTICS AND PLACEBO IN
HEALTHY ADULT PATIENTS WHO UNDERWENT URETERORENOSCOPIC
SURGERY
Tsai-Feng Chen 1, Yuan-Ju Lee 2. 1Division of Urology, Department of Surgery,
Cardinal Tien Hospital and Fu-Jen Catholic University, Taipei, Taiwan;
2Department of Urology, National Taiwan University Hospital, Taipei, Taiwan
Purpose: To compare the efﬁcacy of prophylactic antibiotics in reduction
of post-operative infections in patients undergoing ureterorenoscopy
(URS) as the intervention.
Materials and Methods: The study is a open-labeled, prospective, ran-
domized controlled trial. Between 2013 to 2014, 63 patients with preop-
erative sterile urine undergoing URS were randomly and equally allocated
by the randomization to three groups, and each group received prophy-
lactic antibiotics with single-dose intravenous cefazolin (1gm), oral
cefuroxime (500mg) or placebo (control group), respectively. The Urine
analysis and urine cultures were obtained around postoperative day 5 to 7.
We deﬁned pyuria as WBCS 10/HPF at urine sediment study, and signif-
icant bacteriuria was deﬁned as S105 CFU pathogens/ml in the urine..
Febrile urinary tract infection (fUTI) was deﬁned as body temperature
more than 38 Celsius degree with pyuria or signiﬁcant bacteriuria within 7
days post-operatively.
Results: Total 61 patients were recruited for the analysis. The post-
operative pyuriawere signiﬁcantly lower in patients with prophylaxis than
the placebo group. Patients receiving prophylactic antibiotics with cefa-
zolin and oral cefuroxime were subjected to signiﬁcantly lower risks of
pyuria compared with the control group (23.8% and 30% vs. 60.%, p<0.05).
There are the trends that the rate of bacteriuria was lower in patients
underwent prophylaxis, though it was not statistically signiﬁcant (12.2% vs
30%, p¼ 0.15) There was no signiﬁcant difference in rate of fUTI between
patients with abx prophylaxis and the placebo group. (1% vs. 0%, p¼ 1).
Conclusions: Antibiotic prophylaxis signiﬁcantly reduces the incidence of
pyuria following URSL and tends to decreased the risk of bacteriuria.
MP4-3:
ROBOTIC-ASSISTEDURETEROURETEROSTOMY/URETERONEOCYSTOSTOMY
FOR THE TREATMENT OF INTRINSIC URETERAL ENDOMETRIOSIS RELATED
OBSTRUCTIVE UROPATHY e A PRELIMINARY EXPERIENCE OF A SINGLE
ACADEMIC CENTER
Wei-Jen Chen 1, Eric Yi-Hsiu Huang 1,3,5, Yi-Jen Chen 2,4, Alex T.L.
Lin 1,3,5, Kuang-Kuo Chen 1,3,5. 1Department of Urology, Taipei Veterans
General Hospital, Taiwan; 2Department of Obstetrics and Gynecology,
Taipei Veterans General Hospital, Taiwan; 3Department of Urology, School
of Medicine, National Yang-Ming University, Taiwan; 4Department of
Obstetrics and Gynecology, School of Medicine, National Yang-Ming
University, Taiwan; 5 Shu-Tien Urological Science Research Center, Taiwan
Purpose: Endometriosis occurred in 10e15% of women of childbearing
age. Ureteral involvement is a rare manifestation of endometriosis and
occurs in only about 0.1% of women. The diagnosis is challenging since up
to 50% of patients are asymptomatic and may cause silent kidney or pro-
gressive renal function loss. There is no high evidence based treatment
protocol available currently. Literature is limited in case series and lapa-
roscopic resection of the endometriosis tissue seems to be the preferredmanagement now. Robotic-assisted management of ureteral endometri-
osis is a viable option but was scarcely reported. We reported 4 cases of
ureteral endometriosis with severe obstructive uropathy successful
treated by robotic-assisted segmental resection and ureteroureterostomy
or ureteroneocystostomy (RUU or RUC).
Materials and Methods: From January 2013 to September 2015, 3 women
received RUU and 1 woman received RUC due to ureteral endometriosis
related obstructive uropathy were reviewed.
Results:Mean agewas 36.25 year old (range 29e48), with mean follow-up
time 12.5 months (range 3e32). One patient was incidentally found to
have hydronephrosis, and 3 patients were initially presented with ipsi-
lateral ﬂank pain. All patients had normal serum creatinine (range
0.62e0.97mg/dl) preoperatively. Diagnosis was proved by MRI imaging.
The mean time of hydronephrosis to deﬁnitive treatment was 29.25
months (range 2e75). Left lower third ureter was involved in 3 patients,
right lower third ureter was involved in 1 patients. All 4 patients had
previous treatment failure by double-J stenting with or without medical
treatment. Pre-op ureteroscopy had been performed in all 4 patients, but
only 1 patient had endometriosis tissue invasion conﬁrmed by uretero-
scopic biopsy. Double-J stenting was performed for all the patients intra-
operatively and was removed 4e6 weeks after the operation. The proximal
and distal ureter cut ends were examined by frozen section during the
operation to ensure free of endometriosis tissue. Permanent pathology
reports all conﬁrmed endometrial glands in the ureteral wall. One patient
received myomectomy together, and another patient received hysterec-
tomy and left oopherectomy simultaneously. The mean blood loss was
132.5cc (range 30e250). No complication occurred. All patient received
diphereline treatment for 6 months after the operation. Follow-up so-
nography at post-op 3 months all showed resolves of hydronephrosis. Two
patients with follow-up of more than one year were free of
hydronephrosis.
Conclusion: Our experiences proved the feasibility and efﬁcacy of robotic-
assisted approach in this rare situation. The preliminary results seemed
promising and prospective patient enrollment is undergoing.
MP4-4:
A COHORT STUDY OF INTERSTITIAL CYSTITIS/BLADDER PAIN
SYNDROME (IC/BPS) AND HYSTERECTOMY IN TAIWAN: A
NATIONWIDE POPULATION-BASED, PROPENSITY SCOREeMATCHED
COHORT STUDY
Kun-Min Chang 1,2, Ming-Huei Lee 2,3, Shang-Liang Wu4, Hsuan-Hung
Lin 2, Hsiu-Ying Lin 5, Huei-Ching Wu2,3. 1Department of Obstetrics and
Gynecology, Feng Yuan Hospital, Ministry of Health and welfare, Taichung,
Taiwan, Republic of China; 2Central Taiwan University of Science and
Technology, Taichung, Taiwan, Republic of China; 3Department of Urology,
Feng Yuan Hospital, Ministry of Health and welfare, Taichung, Taiwan,
Republic of China; 4Centre for Environment and Population Health, Grifﬁth
University, Australia; 5Department of anaesthesiology, Feng Yuan Hospital,
Ministry of Health and welfare, Taichung, Taiwan, Republic of China
Purpose: Symptoms of Interstitial Cystitis/Bladder Pain Syndrome (IC/BPS)
are often confused with uterine conditions. Gynecologists may therefore
recommend hysterectomy for these patients. We investigate if IC/BPS in-
creases the risk of hysterectomy in a large nationwide cohort study.
Materials and Methods: We performed a retrospective cohort study of
Longitudinal Health Insurance Database 2010 with newly diagnosis of fe-
male IC/BPS from 2002 through 2013. After limiting our sample to female
patients with IC/BPS diagnosis (ICD-9 code 595.1 at least once during the
study period), we identiﬁed the IC/BPS cohort. We then excluded female
patients who had been received hysterectomy (ICD-9 procedures codes,
68.4, 68.41, 68.49, 68.51, 68.59) before IC diagnosis. We deﬁned the logit of
predicted probability of hysterectomy as a propensity score using the
confounding factors including age and ﬁve comorbidities. Subjects with IC/
BPS were matched on a one-to-one basis with subjects without IC/BPS by
propensity score. The primary outcome was the event of hysterectomy
after the entry dates. The hazard ratio (HR) of hysterectomy in the IC/BPS
cohort was compared with the non-IC/BPS cohort by Cox regression after
adjusting for confounding factors.
Results: After matched by propensity score, we identiﬁed an IC/BPS cohort
with 1507 female subjects and a matched non-IC/BPS cohort with 1507
